Tudorza Pressair is a long-acting anticholinergic indicated for long-term, maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema. Tudorza produces bronchodilation by inhibiting the muscarinic M3 receptor in the airway smooth muscle. The bronchodilation following inhalation of aclidinium bromide is predominantly a site-specific effect.
Tudorza is a preloaded Pressair inhaler available in 30- or 60-metered doses containing 400mcg per actuation.
For more information call (800) 678-1605 or visit www.tudorza.com.